R&D Systems™ Recombinant Canine HGF Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity, Binding Activity

Description

The Recombinant Canine HGF Protein is derived from Sf 21 (baculovirus). The Recombinant Canine HGF Protein has been validated for the following applications: Bioactivity, Binding Activity.

Specifications

• Gene ID (Entrez): 403441
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A
• Recombinant: Recombinant

• Name: HGF
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived canine HGF protein Arg28-Arg494 (Lys266Gln,Trp321Arg,Leu458Pro) ( alpha chain) & Val495-Ser730 (Ile693Thr) ( beta chain)
• Structural Form: Disulfide-linked heterodimer
• Conjugate: Unconjugated
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.